RT @CIR_AACR: An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn mo…
RT @Adri_CIR: #AACRtii21 Amazing talk by Dr. Haigis! Take a look at this @CIR_AACR study from @HaigisLab and #ArleneSharpe on a screening p…
Pharmacologic Screening Identifies #Metabolic Vulnerabilities of #CD8_T Cells https://t.co/AV13G4MYCD
#AACRtii21 Amazing talk by Dr. Haigis! Take a look at this @CIR_AACR study from @HaigisLab and #ArleneSharpe on a screening platform that ID's metabolic vulnerabilities in #CD8+ #Tcells! @isaac_s_harris @DrijversJefte @MuijlwijkTara #Immunometabolism http
RT @Adri_CIR: Hey #AAI2021! Interested in #immunometabolism? Take a look at this @HaigisLab and #ArleneSharpe @CIR_AACR study on a screenin…
Hey #AAI2021! Interested in #immunometabolism? Take a look at this @HaigisLab and #ArleneSharpe @CIR_AACR study on a screening platform that ID'd metabolic vulnerabilities in #CD8+ #Tcells! @isaac_s_harris @DrijversJefte @MuijlwijkTara https://t.co/JPJUj0m
Hey #AACR21 👋👋Take a look at this @HaigisLab and #ArleneSharpe study on a screening platform that ID's metabolic vulnerabilities in #CD8+ #Tcells! @CIR_AACR #Immunometabolism https://t.co/JPJUj0mehJ
#AACR21 Take a look at this @HaigisLab and #ArleneSharpe @CIR_AACR study on a screening platform that ID's metabolic vulnerabilities in #CD8+ #Tcells! #Immunometabolism https://t.co/JPJUj04Dqb
RT @CIR_AACR: An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn mo…
RT @CIR_AACR: An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn mo…
An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn more: @MuijlwijkTara @isaac_s_harris @DrijversJefte @HaigisLab https://t.co/wvOvFmsDcD https://t.co/9I31u7uFr8
RT @CIR_AACR: An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn mo…
RT @CIR_AACR: An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn mo…
RT @CIR_AACR: An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn mo…
RT @CIR_AACR: An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn mo…
An in vitro pharmacologic #screening platform identifies #ferroptosis as a metabolic vulnerability in #CD8+ #Tcells. Learn more: @MuijlwijkTara @isaac_s_harris @DrijversJefte @HaigisLab https://t.co/dfOGioo2fq https://t.co/cw3vpmrUS2
RT @Adri_CIR: #VKSTumor21 Awesome talk by Dr. Haigis! Take a look at this @HaigisLab and #ArleneSharpe @CIR_AACR study on a screening platf…
RT @Adri_CIR: #VKSTumor21 Awesome talk by Dr. Haigis! Take a look at this @HaigisLab and #ArleneSharpe @CIR_AACR study on a screening platf…
RT @Adri_CIR: #VKSTumor21 Awesome talk by Dr. Haigis! Take a look at this @HaigisLab and #ArleneSharpe @CIR_AACR study on a screening platf…
#VKSTumor21 Awesome talk by Dr. Haigis! Take a look at this @HaigisLab and #ArleneSharpe @CIR_AACR study on a screening platform that ID'd metabolic vulnerabilities in #CD8+ #Tcells!👇 @isaac_s_harris @DrijversJefte @MuijlwijkTara #Immunometabolism https://
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
Dr. Marcia Haigis and @HaigisLab scientists measure the cell type–specific sensitivities of activated CD8+ T cells and B16 melanoma cells to a wide array of metabolic perturbations during antigen-specific killing of cancer cells by CD8+ T cells. @CIR_AACR
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @mela927: New paper from our lab! So happy I got to see this story unfold from the very beginning. Congrats @DrijversJefte 🎉 https://t.c…
Congrats @DrijversJefte!
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
Super fortunate to have played a small role in this awesome work. Congrats!!!
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
New paper from our lab! So happy I got to see this story unfold from the very beginning. Congrats @DrijversJefte 🎉
RT @HaigisLab: (1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeu…
New work from our grad student @DrijversJefte! He developed a cool screening approach to uncover CD8+ T-cell liabilities and found that they're more sensitive to ferroptosis inhibitors than cancer cells, affecting their anti-tumor activity. Glad to see you
(1/4) T cells and cancer cells rely on many of the same metabolic pathways, so how to selectively boost the T cells therapeutically? We developed an in vitro screening platform to compare the metabolic sensitivities of CD8+ T cells and cancer cells. https:
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells. https://t.co/U9frx1ZLbr https://t.co/2LvpHNVkzK